Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
Armitage
J O
JO
Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009181:Mycoses / Q000188:drug therapy; D009369:Neoplasms / Q000628:therapy; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; C081222:sargramostim; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim